Chiesi unveils €430M investment to revitalize Italian production site for inhaler, biologics manufacturing
As part of an ongoing expansion strategy around the globe, Chiesi announced this week that it will invest 430 million euros (roughly $464 million) to build a new facility for inhalers and other health products in the Nerviano municipality of the Italian city of Milan, while also revitalizing a decades old production site there.
